Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.63 USD | -1.36% |
|
-6.68% | +3.42% |
06-13 | Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease | CI |
05-08 | Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study | MT |